The global clinical microbiology market size is expected to reach USD 16.7 billion
by 2025, according to a new report by Grand View Research, Inc. It is projected
to expand at a CAGR of 6.7% over the forecast period. Clinical microbiology
depends on technical and skilled workforce to process and interpret results of
clinical specimens. Clinical staff have been complaining about poor Turnaround
Time (TAT) of tests. However, with technological advancements, a number of
laboratory instruments and equipment are being replaced with automated devices
to minimize human error and dependency on skilled workforce.
In addition, automation has benefits such as reduced TAT and use of
labor and lab space, thereby reducing overall cost associated with these tests.
Manufacturers are focusing on introduction of automatic specimen processing,
plate reading, and organism identification. GE Healthcare, PerkinElmer, and
Thermo Fisher are some of the key players offering automated systems in the
diagnostics industry.
Rising cases of hospital-acquired infections (HAI) is also fueling
demand for clinical microbiology for diagnosis and monitoring. As high-income
countries are stepping up their pursuit of countering hospital-acquired
infections, middle- and low-income countries are recognizing the threat. Introduction
of automated systems and innovative designs is expected to intensify market
competition and change market dynamics over the forecast period.
The World Health Organization (WHO) is particularly active in countries
such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where occurrence
of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI
diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan,
and Bhutan are also actively participating in HAI awareness programs. India and
China are projected to be the main countries driving demand for HAI diagnostics
instruments and tests in future.
Full Research Report On Clinical Microbiology
Market Analysis:
https://www.grandviewresearch.com/industry-analysis/clinical-microbiology-market
https://www.grandviewresearch.com/industry-analysis/clinical-microbiology-market
Further key findings from the study suggest:
·
Owing to rapid adoption of technology and
automation of work flow, laboratory instruments are expected to form the
fastest growing segment over the forecast period
·
Reagents captured the largest revenue share
in 2016 owing to repeat purchase of reagents
·
In 2015, North America dominated the global
market. Continuous research on infectious disease treatment and subsequent
grants from government healthcare agencies are contributing to development of a
strong ecosystem in the region
·
Asia Pacific is expected to emerge as the
fastest growing region during the forecast period owing to rising geriatric
population in India, China, and Japan. This has resulted in high prevalence of
re-emerging infectious diseases such as tuberculosis, cholera, and typhoid
·
The clinical microbiology market is
presently dominated by a few key participants such as bioMerieux S.A.; Cepheid
Inc.; Danaher Corporation; and Bruker Corporation
·
Other prominent players operating in the
market include Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics;
and Alere Inc.
View More Reports Of This Category By Grand View Research
At: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research
has segmented the global clinical microbiology market on the basis of product,
application, and region:
Clinical Microbiology Product
Type Outlook (Revenue, USD Million, 2014 - 2025)
·
Laboratory Instruments
o Incubators
o Gram Stainers
o Bacterial Colony Counters
o Autoclave Sterilizers
o Petri Dish Fillers
o Automated Culture Systems
·
Microbiology Analyzers
o Molecular Diagnostic Instruments
o Microscopes
o Mass Spectrometers
·
Reagents
Clinical Microbiology
Application Type Outlook (Revenue, USD Million, 2014 - 2025)
·
Respiratory Diseases
·
Bloodstream Infections
·
Gastrointestinal Diseases
·
Sexually Transmitted Diseases
·
Urinary Tract Infections
·
Periodontal Diseases
·
Other Diseases
Clinical Microbiology
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o U.K.
·
Asia Pacific
o China
o India
o Japan
·
Latin America
o Mexico
o Brazil
·
Middle East and Africa
o South Africa
Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-clinical-microbiology-market
https://www.grandviewresearch.com/press-release/global-clinical-microbiology-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/
No comments:
Post a Comment